Is It Possible to Establish the Extent of Resection of Glioblastoma With 18F-Fluorocholine PET/CT?

Defining high-grade glioma resectability is a challenge; and currently, it is based on anatomical imaging. However, complete removal of contrast-enhancing tumor is difficult to define in MRI. We present three cases of patients diagnosed with high-grade glioma. Brain MRI and F-fluorocholine PET/CT we...

Full description

Saved in:
Bibliographic Details
Published inClinical nuclear medicine Vol. 43; no. 8; p. e269
Main Authors García Vicente, Ana María, Perez-Beteta, Julian, Calvo García, Manuel, Villena Martín, Maikal, Soriano Castrejón, Angel
Format Journal Article
LanguageEnglish
Published United States 01.08.2018
Subjects
Brain Neoplasms - diagnostic imaging
Fluorodeoxyglucose F18
Glioblastoma - diagnostic imaging
Humans
Magnetic Resonance Imaging
Positron Emission Tomography Computed Tomography
Radiopharmaceuticals
Online AccessGet more information

Cover

More Information
Summary:Defining high-grade glioma resectability is a challenge; and currently, it is based on anatomical imaging. However, complete removal of contrast-enhancing tumor is difficult to define in MRI. We present three cases of patients diagnosed with high-grade glioma. Brain MRI and F-fluorocholine PET/CT were performed before and after surgery to establish the extent of resection (EOR) and residual volume. Postoperative brain MRI and PET parameters showed discordant results in all the reported cases. PET was able to assess properly the EOR; however, the rules for the EOR establishment and its prognostic implication should be validated in prospective studies.
ISSN:1536-0229
DOI:10.1097/RLU.0000000000002153